Helus Pharma partners with TARA Mind to recruit veterans for HLP003 Phase 3

Helus Pharma (formerly Cybin) (HELP) — Helus Pharma said it is collaborating with veterans-focused organization TARA Mind to support recruitment for the PARADIGM Phase 3 program evaluating HLP003 in major depressive disorder.

The partnership aims to expand mental-health awareness and trial participation within the veteran community. It signals continued execution on the company's lead depression program despite the recent CEO transition.

Source: stocktitan.net

For the rest of that week's sector news, read our week in review.